Jula Veerapong

Publications

• Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a Prospective Clinical Trial and Comparative Analysis
  Surgical Endoscopy. Dec, 2022  |   Pubmed ID: 36477643
• Influence of Insurance Status on the Postoperative Outcomes of Cytoreductive Surgery and HIPEC
  Journal of Surgical Oncology. Dec, 2022  |   Pubmed ID: 36468401
• ASO Visual Abstract: Conditional Survival After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative
  Annals of Surgical Oncology. Nov, 2022  |   Pubmed ID: 36418799
• ASO Visual Abstract: Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?
  Annals of Surgical Oncology. Nov, 2022  |   Pubmed ID: 36369408
• Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative
  Annals of Surgical Oncology. Oct, 2022  |   Pubmed ID: 36310315
• Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?
  Annals of Surgical Oncology. Oct, 2022  |   Pubmed ID: 36305990
• Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study
  Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract. Dec, 2022  |   Pubmed ID: 36258061
• Alvimopan for Enhanced Gastrointestinal Recovery After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Randomized Controlled Trial
  Journal of the American College of Surgeons. Nov, 2022  |   Pubmed ID: 36102565
• An Ex Vivo Organotypic Culture Platform for Functional Interrogation of Human Appendiceal Cancer Reveals a Prominent and Heterogenous Immunological Landscape
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2022  |   Pubmed ID: 36067351
• Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery
  JAMA Network Open. May, 2022  |   Pubmed ID: 35612856
• Pregnancy-associated Large Pelvic Desmoid Tumor: A Case Report of Fetal-protective Strategies and Fertility Preservation
  Gynecologic Oncology Reports. Feb, 2022  |   Pubmed ID: 35531359
• Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease?
  The Journal of Surgical Research. Sep, 2022  |   Pubmed ID: 35525209
• Prognostic Significance of Preoperative Tumor Markers in Pseudomyxoma Peritonei from Low-Grade Appendiceal Mucinous Neoplasm: a Study from the US HIPEC Collaborative
  Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract. Feb, 2022  |   Pubmed ID: 34506026
• Ki67 Does Not Predict Recurrence for Low-grade Appendiceal Mucinous Neoplasms with Peritoneal Dissemination After Cytoreductive Surgery and HIPEC
  Human Pathology. Jul, 2021  |   Pubmed ID: 33905776
• The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative
  Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract. Nov, 2021  |   Pubmed ID: 33634422
• Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis
  Annals of Surgical Oncology. Aug, 2021  |   Pubmed ID: 33507449
• A Multi-institutional Analysis of Textbook Outcomes Among Patients Undergoing Cytoreductive Surgery for Peritoneal Surface Malignancies
  Surgical Oncology. Jun, 2021  |   Pubmed ID: 33465587
• A Multi-institutional Study of Peritoneal Recurrence Following Resection of Low-grade Appendiceal Mucinous Neoplasms
  Annals of Surgical Oncology. Aug, 2021  |   Pubmed ID: 33415564
• HIPEC After Neoadjuvant Chemotherapy and Interval Debulking is Associated with Development of Platinum-refractory or -resistant Disease
  Gynecologic Oncology. Apr, 2021  |   Pubmed ID: 33293046
• A Novel Preoperative Risk Score to Optimize Patient Selection for Performing Concomitant Liver Resection with Cytoreductive Surgery/HIPEC
  Journal of Surgical Oncology. Jan, 2021  |   Pubmed ID: 33002202
• Preoperative Bevacizumab Does Not Increase Complications Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  PloS One. 2020  |   Pubmed ID: 33270763
• CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does Not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative
  Annals of Surgical Oncology. Dec, 2020  |   Pubmed ID: 33073341
• Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or Without Hyperthermic IntraPEritoneal Chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations - Part I: Preoperative and Intraoperative Management
  European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. Dec, 2020  |   Pubmed ID: 32873454
• Comparison of Open and Closed Hyperthermic Intraperitoneal Chemotherapy: Results from the United States Hyperthermic Intraperitoneal Chemotherapy Collaborative
  World Journal of Gastrointestinal Oncology. Jul, 2020  |   Pubmed ID: 32864043
• Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or Without Hyperthermic IntraPEritoneal Chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations - Part II: Postoperative Management and Special Considerations
  European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. Dec, 2020  |   Pubmed ID: 32826114
• Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases
  Annals of Surgical Oncology. Sep, 2020  |   Pubmed ID: 32767050
• Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative
  Annals of Surgical Oncology. Dec, 2020  |   Pubmed ID: 32696303
• Predictors of Non-home Discharge After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  The Journal of Surgical Research. Nov, 2020  |   Pubmed ID: 32622162
• The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPEC
  Annals of Surgical Oncology. Dec, 2020  |   Pubmed ID: 32378087
• Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study
  Annals of Surgical Oncology. Dec, 2020  |   Pubmed ID: 32318945
• Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review
  Journal of Clinical Medicine. Mar, 2020  |   Pubmed ID: 32164300
• Detection of Mesenteric Tumor Using Dynamic Contrast Enhanced MRI
  Annals of Surgical Oncology. Jul, 2020  |   Pubmed ID: 32157527
• What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative
  Clinical Colorectal Cancer. Mar, 2020  |   Pubmed ID: 31974019
• Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study
  Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract. Jan, 2020  |   Pubmed ID: 31745888
• Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?
  Annals of Surgical Oncology. Mar, 2020  |   Pubmed ID: 31659645
• Trends in the Indications for and Short-term Outcomes of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
  American Journal of Surgery. Mar, 2020  |   Pubmed ID: 31558307
• Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative
  Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract. Jan, 2020  |   Pubmed ID: 31428960
• Obstruction-Free Survival Following Operative Intervention for Malignant Bowel Obstruction in Appendiceal Cancer
  Annals of Surgical Oncology. Oct, 2019  |   Pubmed ID: 31190209
• Incidence, Risk Factors, and Prevention Strategies for Venous Thromboembolism After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  Annals of Surgical Oncology. Jul, 2019  |   Pubmed ID: 31065960
• Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study
  Annals of Surgical Oncology. Jul, 2019  |   Pubmed ID: 31016486
• Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?
  Annals of Surgical Oncology. May, 2019  |   Pubmed ID: 30815802
• Cytoreductive Surgery and Normothermic Intraperitoneal Chemotherapy for Signet Ring Cell Appendiceal Adenocarcinoma With Peritoneal Metastases in the Setting of Cirrhosis
  Gastroenterology Research. Jun, 2018  |   Pubmed ID: 29915638